Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Cancer ; 154(9): 1639-1651, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38212905

ABSTRACT

TRPS1 is aberrantly expressed in a variety of tumors, including breast, prostate, and gastric cancers, and is strongly associated with tumorigenesis or prognosis. However, the role of TRPS1 in high grade serous ovarian carcinoma (HGSC) is unknown. We investigated the relationship between TRPS1 expression and clinicopathology in HGSC patients. The tumor-related regulatory mechanisms of TRPS1 was explored through in vivo and vitro experiments. The results showed that TRPS1 was highly expressed in HGSC compared to normal tissues. It was also linked to the cell proliferation index Ki67 and poor prognosis. In vivo experiments showed that knockdown of TRPS1 could inhibit tumor growth. In vitro experiments, knockdown of TRPS1 inhibited the proliferation of ovarian cancer cells. TRPS1 exerted its regulatory role as a transcription factor, binding to the PSAT1 promoter and promoting the expression of PSAT1 gene. Meanwhile, PSAT1 was positively correlated with CCND1 expression. These results suggest that TRPS1 affects HGSC proliferation and cell cycle by regulating PSAT1 and thus CCND1 expression.


Subject(s)
Cystadenocarcinoma, Serous , Ovarian Neoplasms , Male , Female , Humans , Cystadenocarcinoma, Serous/pathology , Ovarian Neoplasms/pathology , Transcription Factors/genetics , Prognosis , Cell Proliferation , Repressor Proteins/genetics
2.
Cell Biol Toxicol ; 39(6): 3141-3157, 2023 12.
Article in English | MEDLINE | ID: mdl-37531013

ABSTRACT

Infertility has attracted global concern, and disruption of testosterone is a common cause of male infertility. Exploring the critical factors in testosterone biosynthesis may provide new insights for disease research and clinical therapy. Research on trichorhinophalangeal syndrome-1 (Trps1) gene has recently been focus on cancers; it is yet unknown whether Trps1 produces a marked effect in the male reproductive system. In the current study, single-cell RNA sequencing analysis of trichorhinophalangeal syndrome-1 gene (Trps1) expression in mouse testes and cleavage under targets and tagmentation and RNA sequencing were utilized to investigate the functionality of Trps1 in mouse Leydig cells. Knockdown of Trps1 increased testosterone synthesis in vitro and vivo using adeno-associated viral delivery and conditional knockout models. The results showed that Trps1 was abundantly expressed in Leydig cells. The expression levels of both steroidogenic factor-1 (Sf-1) and steroidogenic enzymes (Cyp11a1, Hsd3b, Cyp17a1, and Hsd17b3) as well as testosterone secretion were increased after Trps1 deficiency in vivo and vitro. Furthermore, disruption of Trps1 reduced histone deacetylase 1/2 activity and increased histone H3 acetylation in the Sf-1 promoter, thereby promoting testosterone secretion. Interestingly, Sf-1 also regulated the transcription of Trps1 through activating transcription factor 2. These results indicate that Trps1 targets Sf-1 to affect steroidogenesis through histone acetylation and shed light on the critical role of Trps1 functioning in the mouse Leydig cells.


Subject(s)
Leydig Cells , Testosterone , Mice , Animals , Male , Leydig Cells/metabolism , Base Sequence , Promoter Regions, Genetic , Repressor Proteins/genetics
3.
Oxid Med Cell Longev ; 2022: 1361135, 2022.
Article in English | MEDLINE | ID: mdl-36589683

ABSTRACT

Dysregulation of eukaryotic translation initiation factor 1A, X-linked (EIF1AX), has been implicated in the pathogenesis of some cancers. However, the role of EIF1AX in endometrial carcinoma (EC) remains unknown. We investigated the EIF1AX expression in EC patients and assessed its tumorigenesis-associated function and nucleocytoplasmic transport mechanism in vitro and in vivo. The results indicated that the cytoplasmic EIF1AX expression showed a gradual increase when going from endometrium normal tissue, simple endometrial hyperplasia, complex endometrial hyperplasia, and endometrial atypical hyperplasia to EC, while vice versa for the nuclear EIF1AX expression. In addition, the cytoplasmic EIF1AX expression was positively correlated with histologic type, high International Federation of Gynecology and Obstetrics (FIGO) grade, advanced FIGO stage, deeper infiltration, high Ki67 index, and shorter recurrence-free survival in EC patients. In vitro, short hairpin RNA-mediated EIF1AX depletion or SV40NLS-mediated EIF1AX import into the nucleus in multiple human EC cells potently suppressed cell migration and invasion, epithelial-mesenchymal transition, and lung metastasis. Moreover, exportin 1 induced the transport of EIF1AX from the nucleus to the cytoplasm that could be inhibited by leptomycin B treatment or the mutation in the EIF1AX location sequence. These results demonstrate that cytoplasmic EIF1AX may play a key role in the incidence and promotion of EC, and thus, targeting EIF1AX or its nucleocytoplasmic transport process may offer an effective new therapeutic approach to EC.


Subject(s)
Endometrial Hyperplasia , Endometrial Neoplasms , Eukaryotic Initiation Factor-1 , Receptors, Cytoplasmic and Nuclear , Female , Humans , Cell Line, Tumor , Cell Proliferation , Cytoplasm/metabolism , Endometrial Hyperplasia/metabolism , Endometrial Hyperplasia/pathology , Endometrial Neoplasms/genetics , Endometrium/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Eukaryotic Initiation Factor-1/metabolism , Exportin 1 Protein
4.
J Mol Histol ; 50(4): 369-374, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31190160

ABSTRACT

The first cell lineage differentiation occurs during the development of mouse 8-cell embryo to blastocyst. Akt is a potent kinase whose role during blastocyst formation has not been elucidated. In the present study, immunofluorescence results showed that the Akt protein was specifically localized to the outer cells of the morula. Akt-specific inhibitor MK2206 significantly inhibited mouse blastocyst formation and resulted in decreased expression of the trophectoderm marker Cdx2 and led to granular distribution of ERα in the cytoplasm. Furthermore, knockdown of ERα by siRNA microinjection can also lead to a decrease in the development rate of mouse blastocysts, accompanied by a decrease in the expression level of Yap protein. We conclude that Akt may be indispensable for the first cell lineage differentiation of mouse.


Subject(s)
Cell Differentiation , Cell Lineage , Embryo, Mammalian/cytology , Proto-Oncogene Proteins c-akt/physiology , Adaptor Proteins, Signal Transducing/metabolism , Animals , Blastocyst/cytology , Cell Cycle Proteins/metabolism , Embryonic Development , Gene Expression Regulation, Developmental , Mice , Morula/chemistry , YAP-Signaling Proteins
5.
Toxicol Appl Pharmacol ; 378: 114612, 2019 09 01.
Article in English | MEDLINE | ID: mdl-31175881

ABSTRACT

Infertility caused by environmental pollution is becoming a global problem, but an effective prevention or treatment is lacking. Icariin (ICA) is a flavonoid used in traditional Chinese medicine. The present study investigated the possible roles of ICA in preventing testicular dysfunction caused by di(2-ethylhexyl) phthalate (DEHP), one of the most studied environmental endocrine disruptors. Cultured mouse Leydig cells were pretreated with ICA and exposed to DEHP to determine ICA effects upon cell proliferation, reactive oxygen species (ROS) levels, mitochondrial membrane potential (Δψm), testosterone levels and the expression of transcription factor SF-1 and steroidogenic enzymes (CYP11, 3ß-HSD and 17ß-HSD), which play critical roles in androgen production. Our results showed that ICA reversed the adverse effect of DEHP on Leydig cell proliferation, and decreased ROS levels and elevated Δψm levels. Also, ICA promoted testosterone production and up-regulated the expression of SF-1 and steroidogenic enzymes. We investigated ICA actions in vivo, using male mice administrated DEHP followed by ICA. Exposure to DEHP decreased epididymal sperm counts and disrupted seminiferous tubules, and both of these effects were reversed by ICA treatment. These results showed that the mechanisms of ICA in protecting mouse testes against DEHP-induced damage involves the prevention of ROS accumulation and promotion of testosterone secretion.


Subject(s)
Diethylhexyl Phthalate/adverse effects , Flavonoids/pharmacology , Leydig Cells/drug effects , Phthalic Acids/adverse effects , Protective Agents/pharmacology , Testosterone/metabolism , Animals , Cell Proliferation/drug effects , Endocrine Disruptors/metabolism , Female , Leydig Cells/metabolism , Male , Mice , Mice, Inbred ICR , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , Reactive Oxygen Species/metabolism , Spermatozoa/drug effects , Spermatozoa/metabolism , Testis/drug effects , Testis/metabolism
6.
Cell Cycle ; 18(4): 437-451, 2019 02.
Article in English | MEDLINE | ID: mdl-30712485

ABSTRACT

Zygotic genome activation (ZGA) is one of the most critical events at the beginning of mammalian preimplantation embryo development (PED). The mechanisms underlying mouse ZGA remain unclear although it has been widely studied. In the present study, we identified that tricho-rhino-phalangeal syndrome 1 (TRPS1), an atypical GATA family member, is an important factor for ZGA in mouse PED. We found that the Trps1 mRNA level peaked at the one-cell stage while TRPS1 protein did so at the two/four-cell stage. Knockdown of Trps1 by the microinjection of Trps1 siRNA reduced the developmental rate of mouse preimplantation embryos by approximately 30%, and increased the expression of ZGA marker genes MuERV-L and Zscan4d via suppressing the expression of major histone markers H3K4me3 and H3K27me3. Furthermore, Trps1 knockdown decreased the expression of Sox2 but increased Oct4 expression. We conclude that TRPS1 may be indispensable for zygotic genome activation during mouse PED.


Subject(s)
Blastocyst/metabolism , Embryonic Development/genetics , Repressor Proteins/genetics , Repressor Proteins/metabolism , Zygote/metabolism , Animals , Female , Gene Expression Regulation, Developmental , Gene Knockdown Techniques , Histones/genetics , Male , Mice , Microinjections , Octamer Transcription Factor-3/metabolism , Proteins/genetics , RNA, Messenger/genetics , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/pharmacology , SOXB1 Transcription Factors/metabolism , Transcription Factors/genetics , Transcriptional Activation/genetics
7.
Oxid Med Cell Longev ; 2017: 2704532, 2017.
Article in English | MEDLINE | ID: mdl-28680528

ABSTRACT

During in vitro cultivation of preimplantation embryos, the balance between ROS production and clearance is disturbed and may lead to incompetent embryos, which might be a main reason of IVF-ET failure. Icariin (ICA) is reported to be active in clearing ROS. The present study aimed to investigate whether ICA could reverse H2O2 pretreatment-induced mouse preimplantation embryo development arrest and, furthermore, to study the underlying mechanisms by detecting ROS levels, mitochondrial membrane potential (ΔΨm), and zygotic gene expression. The results showed that, after pretreating mouse 1-cell embryos with 40 µM or 60 µM H2O2 for 30 min, the developmental rate of each stage embryos decreased obviously. And by adding 40 µM ICA, the developmental arrest of 60 µM H2O2 pretreated preimplantation embryos was significantly reversed. Immunostaining results showed that, comparing with the control group, ROS levels of H2O2 pretreated 1-cell embryos were elevated and ΔΨm levels decreased. By adding ICA, the ROS levels of H2O2 pretreated 1-cell embryos were decreased and ΔΨm levels were elevated. Furthermore, RT-qPCR results showed that the addition of ICA reversed the H2O2-induced downregulation of eIF-1A mRNA expression levels. These results indicate that ICA, when used in appropriate concentration, could decrease ROS levels, increase ΔΨm levels, and modulate the expression of zygotic gene activation (ZGA) marker gene eIF-1A, and thus promote the development of H2O2-pretreated mouse preimplantation embryos.


Subject(s)
Blastocyst/drug effects , Blastocyst/metabolism , Flavonoids/pharmacology , Hydrogen Peroxide/pharmacology , Animals , Blastocyst/cytology , Female , Mice , Oxidative Stress/drug effects , Pregnancy
8.
Dev Growth Differ ; 58(3): 327-38, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27037955

ABSTRACT

During mouse early embryogenesis, blastomeres increase in number by the morula stage. Among them, the outer cells are polarized and differentiated into trophectoderm (TE), while the inner cells remain unpolarized and give rise to inner cell mass (ICM). TE provides an important liquid environment for ICM development. In spite of extensive research, the molecular mechanisms underlying TE formation are still obscure. In order to investigate the roles of estrogen receptor α (ERα) in this course, mouse 8-cell embryos were collected and cultured in media containing ERα specific antagonist MPP and/or agonist PPT. The results indicated that MPP treatment inhibits blastocyst formation in a dose-dependent manner, while PPT, at proper concentration, promotes the cavitation ratio of mouse embryos. Immunofluorescence staining results showed that MPP significantly decreased the nuclear expression of CDX2 in morula, but no significant changes of OCT4 were observed. Moreover, after MPP treatment, the expression levels of the genes related to TE specification, Tead4, Gata3 and Cdx2, were significantly reduced. Overall, these results indicated that ERα might affect mouse embryo cavitation by regulating TE lineage differentiation.


Subject(s)
Cell Differentiation , Cell Lineage , Ectoderm/metabolism , Estrogen Receptor alpha/metabolism , Trophoblasts/metabolism , 1-Methyl-4-phenylpyridinium/pharmacology , Animals , Base Sequence , Blastocyst Inner Cell Mass/cytology , Blastocyst Inner Cell Mass/metabolism , Blastomeres/cytology , Blastomeres/metabolism , CDX2 Transcription Factor/genetics , DNA-Binding Proteins/genetics , Ectoderm/cytology , Ectoderm/embryology , Estrogen Receptor alpha/agonists , Estrogen Receptor alpha/antagonists & inhibitors , Female , GATA3 Transcription Factor/genetics , Gene Expression Regulation, Developmental/drug effects , Male , Mice , Microscopy, Confocal , Muscle Proteins/genetics , Octamer Transcription Factor-3/genetics , Phenols/pharmacology , Pyrazoles/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , TEA Domain Transcription Factors , Transcription Factors/genetics , Trophoblasts/cytology
9.
Dev Growth Differ ; 58(3): 280-92, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27004788

ABSTRACT

Phosphorylated Ser473-Akt (p-Ser473-Akt) is extensively studied as a correlate for the activity of Akt, which plays an important role in mouse oogenesis and preimplantation embryogenesis. However, little progress has been made about its effect on the mouse zygotic genome activation (ZGA) of 2-cell stage in mouse preimplantation embryos. In this study, we confirmed its localization in the pronuclei of 1-cell embryos and found that p-Ser473-Akt acquired prominent nucleus localization in 2-cell embryos physiologically. Akt specific inhibitors API-2 and MK2206 could inhibit the development of mouse preimplantation embryos in vitro, and induce 2-cell arrest at certain concentrations. 2-cell embryos exposed to 2.0 µmol/L API-2 or 30 µmol/L MK2206 displayed attenuated immunofluorescence intensity of p-Ser473-Akt in the nucleus. Simultaneously, qRT-PCR results revealed that 2.0 µmol/L API-2 treatment significantly downregulated the mRNA pattern of MuERV-L and eIF-1A, two marker genes of ZGA, suggesting a defect in ZGA compared with that of control group. Collectively, our work demonstrated the nuclear localization of p-Ser473-Akt during major ZGA, and Akt specific inhibitors API-2 and MK2206 which led to 2-cell arrest inhibited p-Ser473-Akt from translocating into the nucleus of 2-cell embryos with defective ZGA as well, implying p-Ser473-Akt may be a potential player in the major ZGA of 2-cell mouse embryos.


Subject(s)
Blastocyst/metabolism , Cell Nucleus/metabolism , Embryonic Development , Proto-Oncogene Proteins c-akt/metabolism , Zygote/metabolism , Active Transport, Cell Nucleus/drug effects , Animals , Blastocyst/cytology , Blastocyst/drug effects , Chlorpropamide/analogs & derivatives , Chlorpropamide/pharmacology , Embryo Culture Techniques , Eukaryotic Initiation Factor-1/genetics , Female , Gene Expression Regulation, Developmental/drug effects , Genome/genetics , Heterocyclic Compounds, 3-Ring/pharmacology , Male , Mice , Microscopy, Fluorescence , Phosphorylation/drug effects , Proteins/genetics , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Reverse Transcriptase Polymerase Chain Reaction , Serine/metabolism , Zygote/cytology , Zygote/drug effects
10.
Acta Histochem ; 118(3): 317-21, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26874905

ABSTRACT

Zygotic gene activation (ZGA) is one of the most important events after mouse fertilization, but the mechanisms underpinning it are still unclear. Estrogen receptor alpha (ERα) is a versatile player in animal development. Our preliminary studies showed that ERα-specific antagonists blocked mouse 2-cell development and inhibited ZGA related gene expression, indicating an indispensable role of maternal ERα in early mouse preimplantation embryo development (PED). Here, we performed immunostaining detection to investigate the cell cycle specific subcellular localization of ERα, and serine 118 phosphorylated ERα (pERα-S118), during the first two cleavages of mouse PED. Our results showed that ERα nuclear localization appeared at 1-cell S-phase, disappeared at metaphase, and reappeared since the G1 phase of 2-cell embryos. Nuclear expression of pERα-S118 started at the 1-cell S-phase, but was absent at the G1 phase of 2-cell embryos, and reappeared since the 2-cell S-phase. Interestingly, pERα-S118 showed a dynamic expression pattern among nuclear, nuclear surface, cytoplasm and cell membrane. These results indicate that maternal derived ERα might still function in the first two cleavages of mouse PED, during which ZGA occurs.


Subject(s)
Blastocyst/metabolism , Estrogen Receptor alpha/metabolism , Animals , Blastocyst/cytology , Cell Nucleus/metabolism , Embryonic Development , Female , Gene Expression Regulation, Developmental , Mice, Inbred ICR , Protein Transport
11.
J Steroid Biochem Mol Biol ; 145: 13-20, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25263659

ABSTRACT

Zygotic genome activation (ZGA) is essential for normal development of mammalian preimplantation embryos. Estrogen receptor alpha (ERα) has been implicated in early embryogenesis, and controls the expression of genes associated with proliferation, differentiation and development of cell and target organs via a genomic effect. The objective of this study was to determine whether ERα plays a role in early embryo development and affects ZGA gene expression. Toward this objective, 1-cell embryos from B6C3F1 mouse were cultured with the antiestrogen ICI182780, ERα-specific antagonist MPP, ERα-specific antibody and ERß-specific antagonist PHTPP. Development of 2-cell to 4-cell in vitro was significantly blocked by ICI182780, MPP and ERα-antibody treatment in a dose-dependent manner but not affected by PHTPP exposure. MPP decreased nuclear ERα protein levels and reduced mRNA expression levels of MuERV-L, one of the ZGA related genes. The results indicate that ERα has a functional role in early embryo development by regulation of ZGA-related genes.


Subject(s)
Blastocyst/physiology , Embryonic Development/physiology , Estrogen Receptor alpha/metabolism , Gene Expression Regulation, Developmental , Zygote/metabolism , Animals , Estradiol/analogs & derivatives , Estradiol/chemistry , Estrogen Receptor Antagonists/chemistry , Female , Fulvestrant , Genome , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Proteins/metabolism , RNA, Messenger/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...